June 2, 2021

Emergency care for heart attacks and strokes rebounds

Kaiser Permanente study finds that the decrease reported during the onset of the pandemic was not seen in subsequent surges.

Contact: Susan Rochman

Contact: Kerry Sinclair

OAKLAND, Calif. — The significant declines in heart attack hospitalizations and emergency care for possible strokes seen in Northern California at the beginning of the COVID-19 pandemic were not seen in subsequent surges, new research from Kaiser Permanente shows.

The study, published June 2 in JAMA, suggests public health campaigns that encouraged people to seek care if they were experiencing signs or symptoms of a stroke or heart attack were effective.

“In May 2020, we reported that, in the early months of the pandemic, the weekly number of patients admitted to our hospitals for a heart attack fell to nearly half of what would be expected,” said the study’s lead author Matthew D. Solomon, MD, PhD, a cardiologist for The Permanente Medical Group and a physician researcher with the Kaiser Permanente Northern California Division of Research. “This follow-up study suggests that we were successful in our efforts to reassure patients that it was important to leave their homes and seek emergency care if needed, and that they could do so safely.”

The research team analyzed weekly incidence rates for adults hospitalized with a heart attack or suspected stroke from Jan. 22, 2019, through Jan. 18, 2021, in Kaiser Permanente of Northern California. The team then compared incidence rates for the time periods during the 3 COVID-19 surges in the spring (March 10 through May 4, 2020), summer (June 23 through Aug. 17, 2020), and winter (Nov. 3, 2020, to Jan. 8, 2021) to the same weeks in the prior year.

The study showed weekly hospitalized heart attack and suspected stroke rates declined during the spring COVID-19 surge but then recovered to 2019 rates. During the subsequent and much larger surges in COVID-19 infections and admissions, hospitalization rates for heart attacks remained stable. A small but statistically significant decline in suspected strokes was seen during the summer COVID-19 surge, but the rates rebounded and did not decrease during the largest winter COVID-19 surge.

“In August 2020, we published research that described decreased stroke presentations and discharges, which made us very concerned about patients who would be at risk for long-term disabilities because they were not coming to the hospital for evaluation and treatment,” said study co-author Mai N. Nguyen-Huynh, MD, a research scientist with the Division of Research and the regional director of primary stroke for The Permanente Medical Group. “In response, we redoubled our efforts to educate our patients that if they have stroke symptoms, they should call 911 and go to the nearest stroke center. This study suggests those efforts paid off.”

Kaiser Permanente in Northern California and the Division of Research were ideally positioned to carry out this research. “Our study highlights the unique ability of our embedded regional research team to respond rapidly in collaboration with a multidisciplinary team of clinical and methodological experts to gain insights from our electronic health record data to inform care planning and delivery for a large, diverse population,” said the study senior author, Alan S. Go, MD, associate director of cardiovascular and metabolic conditions research at the Division of Research and regional medical director of clinical trials for The Permanente Medical Group.

The study by Dr. Solomon and Dr. Go that showed hospitalizations fell to nearly half of what would be expected during the first months of the pandemic was published May 19, 2020, in the New England Journal of Medicine. The research by Dr. Nguyen-Huynh and her colleagues on the decrease in stroke patients reporting to the emergency room after the onset of the pandemic was published Aug. 11, 2020, in Stroke.

“Our goal is to stamp out cardiovascular disease,” said Dr. Solomon. “But until then, we want to ensure patients do not delay in seeking needed care.”

This study was supported by the Garfield Memorial Fund, and the Physician Researcher Program and the Delivery Science and Applied Research initiative of The Permanente Medical Group.

Co-authors include Thomas K. Leong, MPH, and Janet Alexander, MSPH, of the Division of Research, and Jamal S. Rana, MD, PhD, and Jeffrey Klingman, MD, of The Permanente Medical Group.

About Kaiser Permanente

Kaiser Permanente is committed to helping shape the future of health care. We are recognized as one of America’s leading health care providers and not-for-profit health plans. Founded in 1945, Kaiser Permanente has a mission to provide high-quality, affordable health care services and to improve the health of our members and the communities we serve. We currently serve approximately 12.5 million members in 8 states and the District of Columbia. Care for members and patients is focused on their total health and guided by their personal Permanente Medical Group physicians, specialists, and team of caregivers. Our expert and caring medical teams are empowered and supported by industry-leading technology advances and tools for health promotion, disease prevention, state-of-the-art care delivery, and world-class chronic disease management. Kaiser Permanente is dedicated to care innovations, clinical research, health education, and the support of community health.